895 results on '"Ting, Jenny P. -Y."'
Search Results
2. Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways
3. Author Correction: Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways
4. The NLR gene family: from discovery to present day
5. Species-specific NLRP3 regulation and its role in CNS autoinflammatory diseases
6. Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine
7. AIM2 in regulatory T cells restrains autoimmune diseases
8. Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration
9. A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases
10. Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection
11. STING-induced regulatory B cells compromise NK function in cancer immunity
12. Inflammasome effector functions: a Tale of Fire and Ice
13. Contributors
14. Author Correction: An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis
15. Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
16. STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant
17. Impact of intracellular innate immune receptors on immunometabolism
18. Author Correction: The NLR gene family: from discovery to present day
19. Dynamic bidirectional regulation of NLRC3 and gammaherpesviruses during viral latency in B lymphocytes
20. Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication
21. Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium.
22. DCAF1 regulates Treg senescence via the ROS axis during immunological aging
23. The TLR2/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primates
24. Landscape and selection of vaccine epitopes in SARS-CoV-2
25. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD
26. The global response to the COVID-19 pandemic: how have immunology societies contributed?
27. Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy
28. A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination
29. The NLRP3 inflammasome: molecular activation and regulation to therapeutics
30. The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy
31. TRAF3IP3 negatively regulates cytosolic RNA induced anti-viral signaling by promoting TBK1 K48 ubiquitination
32. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation
33. Supplementary Figure 1 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
34. Supplementary Table 1 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
35. Supplementary Methods from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
36. Supplementary Figure 6 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
37. Supplementary Figure 7 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
38. Supplementary Figure 3 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
39. Supplementary Figure 2 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
40. Supplementary Figure 5 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
41. Supplementary Figure 4 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
42. Data from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
43. Supplementary Figure Legends 1-7 from The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
44. Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements
45. An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2
46. MAVS-dependent host species range and pathogenicity of human hepatitis A virus
47. Author Correction: AIM2 in regulatory T cells restrains autoimmune diseases
48. Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget’s disease of bone
49. Convergence of Targeted and Immune Therapies for the Treatment of Oncogene-Driven Cancers
50. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.